<SEC-DOCUMENT>0001140361-17-004919-index.html : 20170207
<SEC-HEADER>0001140361-17-004919.hdr.sgml : 20170207
<ACCEPTANCE-DATETIME>20170207165707
ACCESSION NUMBER:		0001140361-17-004919
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20170203
FILED AS OF DATE:		20170207
DATE AS OF CHANGE:		20170207

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bioptix, Inc.
		CENTRAL INDEX KEY:			0001167419
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				841553387
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		1775 38TH STREET
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301
		BUSINESS PHONE:		303-545-5550

	MAIL ADDRESS:	
		STREET 1:		1775 38TH STREET
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Venaxis, Inc.
		DATE OF NAME CHANGE:	20121218

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AspenBio Pharma, Inc.
		DATE OF NAME CHANGE:	20051110

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ASPENBIO INC
		DATE OF NAME CHANGE:	20020213

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Lundy Stephen T.
		CENTRAL INDEX KEY:			0001408113

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33675
		FILM NUMBER:		17579795

	MAIL ADDRESS:	
		STREET 1:		C/O VENAXIS, INC.
		STREET 2:		1585 S. PERRY STREET
		CITY:			CASTLE ROCK
		STATE:			CO
		ZIP:			80104

	FORMER NAME:	
		FORMER CONFORMED NAME:	Lundy Steve
		DATE OF NAME CHANGE:	20070727
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc1.xml
<DESCRIPTION>FORM 4
<TEXT>
Document 1 - file: doc1.html

Document 1 - RAW XML: doc1.xml

</DOCUMENT>
</SEC-DOCUMENT>